UGA scientists pursue new options for biofuel

Farmer harvesting crop

High cost and inefficiency are huge obstacles to biofuels becoming more commonplace. But GRA Eminent Scholars and their colleagues at the University of Georgia are finding novel ways to overcome aspects of those obstacles. An online feature published in October offers a look at these efforts (and provides a good overview of biofuel’s viability as an energy source). Eminent Scholar C.J. Tsai is using CRISPR and other gene-editing tools to speed the breeding of poplar trees and make them more adaptable to climates. Scholar  Robin Buell is re-engineering poplars to maximize their biomass for energy usage. Other researchers are working to change the structure of the cell walls of plants like switchgrass to promote their use as a fuel source. UGA’s contributions to the field could greatly expand America’s capacity for producing billions of gallons of low-carbon biofuels each year. • See the feature >

September 11, 2025
Members are invited to join G2G’s Monthly GBG Reporting Service Webinar on September 18, 2025 . The first portion ( 12:00–12:30 PM ET ) is free and open to all, offering a high-level overview of current federal funding trends. The second half ( 12:30–1:00 PM ET ) is a premium consultation available only to Georgia Life Sciences members, offering direct access to G2G’s expert team—who have helped secure over $550 million in non-dilutive government funding since 2007. Register here: https://www.g2gconsulting.com/event/non-dilutive-funding-g2gs-monthly-gbg-reporting-service-webinar-14-3/2025-09-18/ Key opportunities this month include DARPA’s Expedited Research Innovation System for CBRN threat defense technologies, BARDA’s I-CREATE diagnostic funding and VANGUARD biomanufacturing tools development (each offering up to $200,000), NIAID tuberculosis and influenza research units (up to $1.5–$2.5 million annually), DoD’s $4 million Advanced Medical Monitor development through MTEC, and multiple SBIR opportunities for sensors and field-deployable diagnostics (up to $209,575 for Phase I awards). The September GBG report highlights 13 immunology and infectious disease opportunities, 10 cognitive and brain health programs, and several biotechnology and biomanufacturing initiatives across federal agencies including the Army, ARPA-H, BARDA, and NSF. Georgia Life Sciences members can access the complete 29-page report with detailed deadlines and eligibility requirements [insert link or portal instructions here]. GLS members can access the full 29-page report with deadlines and submission details by logging into your member portal.
By Maria Thacker Goethe September 5, 2025
Protecting U.S. Leadership in Agricultural Biotechnology
By Maria Thacker Goethe August 29, 2025
Celebrating the Next Generation of Scientific Breakthroughs in Georgia
MORE POSTS